Vaccine for Omicron Covid variant - made by China - to be trialed in UAE

An mRNA candidate based on an older coronavirus strain without major mutations, which Abogen co-developed with Walvax Biotechnology and a Chinese military-backed research institution, is being tested in a Phase III trial in China, Mexico and Indonesia.
Mainland China has vaccinated over 88% of its 1.4 billion people against COVID with non-mRNA shots(Representative image)
Mainland China has vaccinated over 88% of its 1.4 billion people against COVID with non-mRNA shots(Representative image)
Published on Apr 30, 2022 01:35 PM IST
Copy Link
Reuters |

China's Suzhou Abogen Biosciences Co on Friday said its Covid-19 vaccine candidate using the messenger RNA (mRNA) technology and targeting the Omicron variant has obtained clinical trial approval in the United Arab Emirates.

With Friday's announcement, Abogen joins Pfizer/BioNTech and Moderna in trialing candidates modified specifically against Omicron, a highly transmissible variant with increased resistance to antibodies elicited by existing shots.

Mainland China has vaccinated over 88% of its 1.4 billion people against COVID with non-mRNA shots. It has not approved any foreign vaccines, although real-world data indicated the two most used Chinese products, manufactured by Sinopharm and Sinovac, have lower effectiveness against COVID infection than mRNA shots from Pfizer/BioNTech and Moderna.

Besides the UAE, Abogen was communicating with regulators in China and other countries on potential clinical trials for the Omicron-specific candidate, it said in a statement.

ALSO READ: Shanghai loosens lockdown norms as Covid eases, over 12 million can leave homes

An mRNA candidate based on an older coronavirus strain without major mutations, which Abogen co-developed with Walvax Biotechnology and a Chinese military-backed research institution, is being tested in a Phase III trial in China, Mexico and Indonesia.

Walvax is also partnering with Shanghai-based startup RNACure to develop a variants-targeting mRNA vaccine candidate, with design different from Abogen's.

Two Omicron-specific vaccine candidates from Sinopharm and one from Sinovac, containing inactivated or "killed" coronavirus, have been cleared for clinical trials in Hong Kong and mainland China.

The UAE regulator has approved clinical trials for a third Omicron-specific candidate from Sinopharm, based on protein, as well as for the firm's two inactivated Omicron-specific candidates, Sinopharm subsidiary China National Biotec Group said on Friday.

SHARE THIS ARTICLE ON
Close Story
QUICKREADS

Less time to read?

Try Quickreads

  • A medical worker takes a swab sample at a nucleic acid testing station, following the coronavirus disease (Covid-19) outbreak, in Beijing. (REUTERS)

    Covid: China halves quarantine time for international travellers

    China on Tuesday slashed the length of its mandatory quarantine for inbound international travellers by half - reducing it to a week from 14 days - in the biggest change to its Covid-19 containment policy yet, signalling a gradual reopening of its borders. The country reported one locally transmitted and 21 asymptomatic Covid cases for Monday.

  • Abortion-rights protesters attend a rally following the United States Supreme Court's decision to overturn Roe v. Wade, federally protected right to abortion, outside the state capitol.

    Instagram, Facebook delete posts offering abortion pills to US women

    Facebook and Instagram have begun promptly removing posts that offer abortion pills to women who may not be able to access them following a Supreme Court decision that stripped away constitutional protections for the procedure. Such social media posts ostensibly aimed to help women living in states where preexisting laws banning abortion suddenly snapped into effect on Friday. Some even offered to mail the prescriptions to women living in states that now ban the procedure.

  • Passengers, some wearing full personal protective equipment, waiting to be transported by bus to their quarantine hotels, after arriving at Pudong International Airport in Shanghai, in January 2022. (AFP)

    Amid flu outbreak in south China, experts warn of dual risk from influenza and Covid: Report

    A flu outbreak in southern China has led to a shortage of medicines with doctors warning of dual health risks from influenza and sporadic Covid-19 outbreaks, a state media report said on Monday. Weakened herd immunity caused by continuous Covid-19 prevention measures,including lockdowns, may be partly to blame for the abnormal spike in influenza cases at this time of the year, experts said, according to a report in the Global Times.

  • Chinese President Xi Jinping hosts the 14th BRICS Summit via video link from Beijing, Thursday, June 23, 2022. (Li Tao/Xinhua via AP)

    Two new countries apply to join BRICS, will 'add value'. Details inside

    Two new countries - Iran and Argentina - have applied to join the increasingly influential BRICS - Brazi, Russia, India, China and South Africa - grouping, an Iranian official said Monday, according to news agency Reuters. The official said Iran's inclusion in BRICS would result in 'added values for both sides'. Argentina president Alberto Fernandez wrote on Telegram '... Argentina and Iran applied to join the BRICS'.

  • China halves quarantine time for overseas travellers

    China halves quarantine time for overseas travellers

    China on Tuesday reduced the length of mandatory quarantine for inbound travellers, in the biggest relaxation of entry restrictions after sticking to a rigid zero Covid policy throughout the pandemic. Read: Indian Navy has questions on China's new aircraft carrier Fujian Since then overseas arrivals have faced weeks of strict monitoring and costly quarantine in hotels and designated centres.

SHARE
Story Saved
×
Saved Articles
Following
My Reads
Sign out
New Delhi 0C
Tuesday, June 28, 2022